MIT and Brigham and Women's Hospital researchers have developed an implantable device, iSOS, that continuously monitors vital signs for opioid overdose and automatically administers naloxone when needed.

MIT and Brigham and Women's Hospital researchers have developed an implantable device, called "iSOS," that continuously monitors vital signs for signs of opioid overdose and automatically administers naloxone, an effective antidote, when needed. The device, about the size of a stick of gum, measures heart and respiratory rate, and successfully reversed overdoses in animal studies 96% of the time. The implantable system could provide a new option for preventing opioid overdose deaths in high-risk populations.

August 14, 2024
22 Articles

Further Reading